StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
United Therapeutics Corp. (UTHR) PT Raised to $660 at TD Cowen, 'remains a top pick'
March 30, 2026 8:33 AM
TD Cowen analyst Joseph Thome raised the price target on United ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
United Therapeutics Corp. (UTHR) PT Raised to $733 at Jefferies
March 30, 2026 10:26 AM
Morgan Stanley on United Therapeutics Corp. (UTHR): project Tyvaso '2030/2035 risk-adjusted sales in IPF of $1.2bn/$2.5bn'
March 30, 2026 8:18 AM
Jefferies on United Therapeutics Corp. (UTHR): expecting '+15–25%' move following positive topline data
March 30, 2026 8:11 AM
Form 8-K UNITED THERAPEUTICS Corp For: Mar 30
March 30, 2026 7:01 AM
United Therapeutics TETON-1 study meets primary endpoint for lung disease treatment
March 30, 2026 7:01 AM
United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso® Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen in TETON-2
March 30, 2026 7:00 AM
Form 4 UNITED THERAPEUTICS Corp For: Mar 26 Filed by: ROTHBLATT MARTINE A
March 27, 2026 4:32 PM
Form 4 UNITED THERAPEUTICS Corp For: Mar 26 Filed by: EDGEMOND JAMES
March 27, 2026 4:32 PM
Form SCHEDULE 13G/A UNITED THERAPEUTICS Corp Filed by: VANGUARD GROUP INC
March 27, 2026 1:54 PM
Form 4 UNITED THERAPEUTICS Corp For: Mar 25 Filed by: ROTHBLATT MARTINE A
March 26, 2026 4:35 PM
Form 4 UNITED THERAPEUTICS Corp For: Mar 26 Filed by: Thompson Tommy G
March 26, 2026 4:35 PM
